NCT03694834 2023-11-28Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial CancerUNC Lineberger Comprehensive Cancer CenterPhase EARLY_PHASE1 Terminated3 enrolled
NCT02646319 2019-06-06Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsMayo ClinicPhase EARLY_PHASE1 Completed2 enrolled